Alessandro Armuzzi

Active 1998–2025

196
Papers
21,037
Citations
68
h-index
176
i10-index

Citations

Citations per year for Alessandro Armuzzi1991: 1 citations1994: 6 citations2001: 7 citations2002: 21 citations2003: 69 citations2004: 66 citations2005: 90 citations2006: 83 citations2007: 88 citations2008: 65 citations2009: 46 citations2010: 57 citations2011: 44 citations2012: 46 citations2013: 53 citations2014: 57 citations2015: 77 citations2016: 92 citations2017: 104 citations2018: 137 citations2019: 599 citations2020: 909 citations2021: 874 citations2022: 789 citations2023: 761 citations2024: 1,246 citations2025: 540 citations2026: 12 citations1992–1993: no citations, so these years are not shown1995–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,413 citing papers, 14.7% of this breakdownItaly: 930 citing papers, 9.7% of this breakdownChina: 763 citing papers, 7.9% of this breakdownUnited Kingdom: 720 citing papers, 7.5% of this breakdownCanada: 543 citing papers, 5.6% of this breakdownFrance: 481 citing papers, 5% of this breakdownGermany: 427 citing papers, 4.4% of this breakdownSpain: 362 citing papers, 3.8% of this breakdownNetherlands: 352 citing papers, 3.7% of this breakdownBelgium: 284 citing papers, 3% of this breakdownJapan: 267 citing papers, 2.8% of this breakdownAustralia: 222 citing papers, 2.3% of this breakdown
0%14.7%Other 29.6%

Fields

  • Biochemistry, Genetics and Molecular Biology58%
  • Medicine29.5%
  • Immunology and Microbiology5.3%
  • Agricultural and Biological Sciences2.9%
  • Nursing1.1%
  • Neuroscience0.9%
  • Other2.3%

Topics

  • Inflammatory Bowel Disease20.5%
  • Microscopic Colitis7.3%
  • Gut microbiota and health4.3%
  • Rheumatoid Arthritis Research and Therapies3.1%
  • Autoimmune and Inflammatory Disorders3%
  • Biosimilars and Bioanalytical Methods2.3%
  • Other59.5%

Coauthors

All papers

Open in search
  1. ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Maaser, Fernando Magro, John K. Marshall, Pär Myrelid, Gianluca Pellino, Isadora Rosa, João Sabino, Edoardo Savarino, Antonino Spinelli, Laurents Stassen, Mathieu Uzzan, Stephan R. Vavricka, Bram Verstockt, Janindra Warusavitarne, Oded Zmora, Gionata Fiorino - Journal of Crohn s and Colitis 2019 cited by 1,344

  2. ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Torsten Kucharzik, Theodore Lytras, Christian Maaser, Fernando Magro, John K. Marshall, Pär Myrelid, Gianluca Pellino, Isadora Rosa, João Sabino, Edoardo Savarino, Laurents Stassen, Joana Torres, Mathieu Uzzan, Stephan R. Vavricka, Bram Verstockt, Oded Zmora - Journal of Crohn s and Colitis 2019 cited by 1,117

  3. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders

    Authors: , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2017 cited by 1,884

  4. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2017 cited by 912

  5. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2016 cited by 2,071

  6. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clint Behrend, Geert Bezemer, Guillaume Bonnaud, Marija Branković, Ik Jang Byung, Xavier Calvet, Karen A. Chachu, Júlio Maria Fonseca Chebli, Jae Hee Cheon, Halina Cichoż‐Lach, Larry Clark, Fraser Cummings, Kunal Dalal, Silvio Danese, Nanne K.H. de Boer, Maria de Lourdes Abreu Ferrari, Étienne Désilets, Predrag Dugalić, George Duvall, Olga Fedorishina, Rafał Filip, Cristina Flores, Ronald Fogel, James Fon, Michael Frankel, Keith Friedenberg, Walter Fries, Vassileva Galina, Piotr Gietka, Rishi Goel, Peter Hasselblatt, Hans Herfarth, László Herszényi, Pieter Hindryckx, Frank Hoentjen, Carmen Horjus Talabur Horje, Satish Iduru, Peter M. Irving, Robert J. Isfort, Vipul Jairath, Michael Jones, Dilara Kalimullina, Jeffry Katz, Manreet Kaur, Sunil K Khurana, Joo Sung Kim, Young‐Ho Kim, D Kleczkowski, Slavko Knezevic, Aaron Knoll, Louis Y Korman, Iskren Kotzev, Andrey Kulyapin, Kang‐Moon Lee, Desirée Leemreis, Jarosław Leszczyszyn, Jimmy K. Limdi, Jack J. Lissauer, Edward V. Loftus, Ewa Małecka‐Panas, John K. Marshall, Emese Mihály, Lukáš Milan, Giovanni Monteleone, Aleksandar Nagorni, Danuta Owczarek, Nichole Palekar, Remo Panaccione, Young Soo Park, Sang Hyoung Park and 43 more - The Lancet 2022 cited by 297

  7. The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2023 cited by 123

  8. Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2020 cited by 317

  9. Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , И. В. Губонина, Stefan Schreiber, Satoshi Motoya, Per M. Hellström, Jonas Halfvarson, James W. Butler, Joel Petersson, Francesca Petralia, Jean‐Frédéric Colombel - Gastroenterology 2020 cited by 238

  10. Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gustav From, Miroslav Fedurco, Milos Gregus, Yoram Bouhnik, Andreas Luegering, Rocco Cosintino, Ivan Bunganic, Jaime Ramos, Mariam Aguas Peris, Olivier Dewit, Mariabeatrice Principi, Emma Wesley, Paula Lago, Stephane Nancey, María Dolores Martín Arranz, Pieter Hindryckx, Ambrogio Orlando, Andrea Geccherle, Maria Laura Annunziata, Bu'hussain Hayee, Jozef Balaz, Francisco Portela, Cyrielle Gilletta, Torsten Kucharzik, Miguel Mínguez, Javier Pérez Gisbert, Ana Gutiérrez Casbas, Edouard Louis, Marco Marino, Gareth Parkes, Fraser Cummings, Bindia Jharap, Jens Kjeldsen, Luís Correia, Paula Ministro, Matthias Ebert, Erik Hertervig, Dirk Staessen, Joris Dutré, Arnaud Colard, Graham Morrison, Henning Glerup, Jens Frederik Dahlerup, Frank Wolfhagen, Marian Batovsky, Martin Molnar, Barbora Kadleckova, Paulo Caldeira, David Laharie, Xavier Hebuterne, Bruno Bonaz, Matthieu Allez, Andreas Fischer, Joaquín Ernesto Hinojosa Del Val, Miriam Mañosa Ciria, Jose Manuel Herrera Justiniano, Charlotte Soderman, Rajiv Chandy, Craig Mowat, Peter Irving, Jan Fallingborg, Jan Matous, Tomas Douda, Romain Altwegg, Jose Manuel Benitez, María Teresa Arroyo Villarino, Jordi Guardiola Capón, Daniel Ginard Vicenc, Pieter Dewint, Sven Almer and 1 more - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 127

  11. Artificial intelligence and inflammatory bowel disease: Where are we going?

    Authors: , , , , , , , , , , , , , , , - World Journal of Gastroenterology 2023 cited by 76

  12. Risankizumab for Ulcerative Colitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Domingo Balderramo, Silvina A. Goncalves, Juan Lasa, Abel Novillo, Orlando Ruffinengo, Sonja Heeren, Walter Reinisch, Filip Baert, Peter Bossuyt, A Colard, Olivier Dewit, Marc Ferrante, Denis Franchimont, Edouard Louis, Jean‐François Rahier, Carlos Fernando de Magalhães Francesconi, Roberto Luiz Kaiser, Rogério Serafim Parra, Lígia Yukie Sassaki, Пламен Пенчев, Desislav Stanchev, Kenneth Atkinson, Melanie Beaton, Talat Bessissow, Susan Greenbloom, Jean-Rene Lachance, Allen Lim, Remo Panaccione, Jean-Michel Samson, Scott Shulman, Jesse Siffledeen, Ignacio Alfaro, Carlos Valenzuela, Gustavo Walsen, Ping An, Qian Cao, Yan Chen, Youxiang Chen, Xiang Gao, Xiaohua Hou, Naizhong Hu, Yan Li, Fei Liu, Mei Liu, LU Lungen, Zhihua Ran, Tongyu Tang, Xin Wang, Shaoqi Yang, Qiang Zhan, Guoxin Zhang, Hu Zhang, Jie Zhang, Xiaolan Zhang, Jie Zhong, Xiaoping Zou, Eligio Álvarez, Juan Ricaurte, Vladimir Borzan, Željko Krznarić, Željko Puljiz, Martin Bortlík, Pavel Svoboda, Jan Ulbrych, Tomáš Vaňásek, Jens Kjeldsen, Lars Kristian Munck, Anja Poulsen, Ezzat Ali, Osama Salem and 257 more - JAMA 2024 cited by 110

  13. The gasdermin protein family: emerging roles in gastrointestinal health and disease

    Authors: , , , - Nature Reviews Gastroenterology & Hepatology 2023 cited by 68

  14. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2014 cited by 921

  15. Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis

    Authors: , , , , , , , , - Clinical Gastroenterology and Hepatology 2022 cited by 102

  16. Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diz-Lois M Palomares, Gionata Fiorino, J M Benítez, Mariabeatrice Principi, Timna Naftali, Carlos Taxonera, G. Mantzaris, Ladislava Sebkova, Beatriz Iade, Donata Lissner, Ferrer I Bradley, Lopez-San A Roman, Ignacio Marín‐Jiménez, Olga Merino, M Sierra, Manuel Van Domselaar, Flavio Caprioli, Iván Guerra, Paula Peixe, Marta Piqueras, Iago Rodríguez–Lago, Yolanda Ber, Karen van Hoeve, P Torres, Marta Gravito‐Soares, Ditte Rudbeck-Resdal, Ottavia Bartolo, Armando Peixoto, Grégory Martin, Alessandro Armuzzi, A Garre, María G. Donday, Martín F J de Carpi, Javier P. Gisbert - The American Journal of Gastroenterology 2018 cited by 171

  17. HLA-DQA1∗05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysis

    Authors: , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2023 cited by 44

  18. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis

    Authors: , , , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2006 cited by 471

  19. Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease

    Authors: , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2020 cited by 86

  20. Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune‐mediated inflammatory diseases: A European retrospective observational study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - United European Gastroenterology Journal 2021 cited by 71

  21. The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease

    Authors: , , , , , , , , , , , , - Digestive and Liver Disease 2020 cited by 111

  22. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Filip Baert, Mauro Bafutto, George Bamias, Isaac Bassan, Curtis A. Baum, Laurent Beaugerie, Brian W. Behm, Pradeep Bekal, M. Catherine Bennett, Fernando Bermejo San José, Charles Bernstein, Dominik Bettenworth, Sudhir Bhaskar, Livia Biancone, Bahri M. Bilir, Michael Blaeker, Stuart Bloom, V. R. Bohman, Francisco Javier Bosques Padilla, Peter Bossuyt, Yoram Bouhnik, Gerd Bouma, Raymond Bourdages, Stephan Brand, Brian Bressler, Markus Brückner, Carsten Buening, Franck Carbonnel, Thomas C. Caves, Jonathon Chapman, Jae Hee Cheon, Naoki Chiba, Camelia Chioncel, Dimitrios Christodoulou, Martin Clodi, Albert Cohen, Gino Roberto Corazza, Richard Corlin, R. Cosintino, Fraser Cummings, Robin Dalal, Silvio Danese, Marc De Maeyer, Carlos Fernando de Magalhães Francesconi, Aminda De Silva, Henry Debinski, Pierre Desreumaux, Olivier Dewit, Geert D’Haens, Sandra Di Felice Boratto, John Nik Ding, Tyler Dixon, Gerald W. Dryden, George Aaron Du Vall, Matthias Ebert, Ana Echarri Piudo, Robert Ehehalt, Magdy Elkhashab, Craig Ennis, Jason Etzel, Jan Fallingborg, Brian Feagan, R Fejes, Daniel Ferraz de Campos Mazo, Valéria Ferreira de Almeida e Borges, Andreas Fischer, Alan M. Fixelle, Mark R. Fleisher, Sharyle Fowler, B. Freilich and 227 more - ˜The œLancet. Gastroenterology & hepatology 2021 cited by 93

  23. Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results

    Authors: , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2022 cited by 85

  24. Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative review

    Authors: , - Digestive and Liver Disease 2021 cited by 123